{
    "organizations": [],
    "uuid": "475e0a55e631b42804e1a1c8cac1d15c20d2e9cd",
    "author": "",
    "url": "https://www.reuters.com/article/brief-capricor-announces-initiation-of-h/brief-capricor-announces-initiation-of-hope-2-clinical-trial-of-cap-1002-for-duchenne-muscular-dystrophy-idUSASC09Y6B",
    "ord_in_thread": 0,
    "title": "BRIEF-Capricor Announces Initiation Of Hope-2 Clinical Trial Of Cap-1002 For Duchenne Muscular Dystrophy",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 31 AM / Updated 27 minutes ago BRIEF-Capricor Announces Initiation Of Hope-2 Clinical Trial Of Cap-1002 For Duchenne Muscular Dystrophy Reuters Staff 1 Min Read\n Capricor Therapeutics Inc:\n* CAPRICOR ANNOUNCES INITIATION OF HOPE-2 CLINICAL TRIAL OF CAP-1002 FOR DUCHENNE MUSCULAR DYSTROPHY Source text for Eikon: Further company coverage:",
    "published": "2018-04-30T14:30:00.000+03:00",
    "crawled": "2018-04-30T14:48:29.010+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "announces",
        "initiation",
        "clinical",
        "trial",
        "duchenne",
        "muscular",
        "dystrophy",
        "reuters",
        "staff",
        "min",
        "read",
        "capricor",
        "therapeutic",
        "inc",
        "capricor",
        "announces",
        "initiation",
        "clinical",
        "trial",
        "duchenne",
        "muscular",
        "dystrophy",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}